ZOLL Medical Corporation, a manufacturer of medical devices and related
software solutions, announced today that the District Court of Munich,
Germany, ruled in favor of ZOLL in granting an injunction against ELan Med
GmbH of Cologne, Germany, for infringing on a ZOLL patent through the
distribution and sale of certain ELan products for use with ZOLL's
Intravascular Temperature Management (IVTM™) systems.
Under the terms of the judgment, ELan has been ordered to stop the manufacture
and sale of infringing products for use with ZOLL's patented temperature
management systems (the Thermogard XP^® and CoolGard 300^® intravascular
temperature management systems). The court also ruled that ZOLL is entitled to
recover damages resulting from sales of the infringing products that were
incurred since January 18, 2012, and ordered ELan to pay 90% of the cost of
the court proceedings.
“We place a high value on our intellectual property and will pursue all
available legal remedies against companies or individuals who attempt to
capitalize on our innovative technologies by patent infringement,” said James
Palazzolo, President of ZOLL. “We are gratified that the court has
acknowledged ZOLL's temperature management system patent.”
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in